EU drugs regulator says to decide on Pfizer vaccine booster in early October By Reuters
© Reuters. FILE PHOTO: Vials of the Pfizer-BioNTech vaccine are pictured in a vaccination centre in Geneva, Switzerland, February 3, 2021. REUTERS/Denis Balibouse
2/2
(Reuters) – The European Medicines Agency (EMA) will likely decide in early October whether to endorse a third dose of the Pfizer-BioNTech COVID-19 vaccine to be given half a year after the initial two-shot course.
“The outcome of this evaluation is expected in early October, unless supplementary information is needed,” the European Medicines Agency’s (EMA) head vaccines strategy, Marco Cavaleri, told a press briefing on Thursday.
Reuters reported earlier in the day that EMA expects to come to a conclusion on booster doses in early October.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
